Mark C. Schiller - 27 Mar 2025 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role: Chief Legal Officer
Signature: /s/ Marc Belsky, Attorney-in-Fact
Issuer symbol: KZR
Transactions as of: 27 Mar 2025
Net transactions value: $0
Form type: 4
Filing time: 01 Apr 2025, 20:42:03 UTC
Previous filing: 05 Mar 2025
Next filing: 03 Jul 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KZR	Employee Stock Option (right to buy)	Award	$0	+4,800	+67%	$0.000000	12,000	27 Mar 2025	Common Stock	4,800	$6.30	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On July 11, 2024, the Reporting Person was granted an option to purchase 12,000 shares of common stock that vests on July 11, 2025, pending the achievement of non-financial performance criteria and continuing service through such date. On March 4, 2025, the Company's Compensation Committee (the "Committee") certified that certain of the non-financial performance criteria were achieved for 7,200 shares underlying the option. On March 27, 2025, the Committee certified that certain of the non-financial performance criteria were achieved for the remaining 4,800 shares underlying the option and as such, the entire option will vest on July 11, 2025, provided the Reporting Person continues to provide service through such date.

Content

On July 11, 2024, the Reporting Person was granted an option to purchase 12,000 shares of common stock that vests on July 11, 2025, pending the achievement of non-financial performance criteria and continuing service through such date. On March 4, 2025, the Company's Compensation Committee (the "Committee") certified that certain of the non-financial performance criteria were achieved for 7,200 shares underlying the option. On March 27, 2025, the Committee certified that certain of the non-financial performance criteria were achieved for the remaining 4,800 shares underlying the option and as such, the entire option will vest on July 11, 2025, provided the Reporting Person continues to provide service through such date.